Cargando…
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
BACKGROUND: Despite the emergence of diagnostic and clinical utility evidence in nephrology, publicly funded access to genomic testing is restricted in most health care systems. To establish genomic sequencing as a clinical test, an evaluation of cost-effectiveness is urgently required. METHODS: An...
Autores principales: | Jayasinghe, Kushani, Wu, You, Stark, Zornitza, Kerr, Peter G., Mallett, Andrew J., Gaff, Clara, Martyn, Melissa, Goranitis, Ilias, Quinlan, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589690/ https://www.ncbi.nlm.nih.gov/pubmed/34805637 http://dx.doi.org/10.1016/j.ekir.2021.08.028 |
Ejemplares similares
-
Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol
por: Jayasinghe, Kushani, et al.
Publicado: (2019) -
Determining the utility of diagnostic genomics: a conceptual framework
por: Mallett, Andrew, et al.
Publicado: (2023) -
Theory Designed Strategies to Support Implementation of Genomics in Nephrology
por: Kansal, Arushi, et al.
Publicado: (2022) -
Renal genetics in Australia: Kidney medicine in the genomic age
por: Jayasinghe, Kushani, et al.
Publicado: (2018) -
Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia
por: Mordaunt, Dylan A, et al.
Publicado: (2023)